Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases”

Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases

(2020) Aristo Vojdani et al.   CLINICAL IMMUNOLOGY

Autoimmunity as the comet tail of COVID-19 pandemic

(2020) Rossella Talotta et al.   World Journal of Clinical Cases

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Off the beaten path: Novel mRNA-nanoformulations for therapeutic vaccination against HIV

(2020) Sigrid D’haese et al.   JOURNAL OF CONTROLLED RELEASE

Nucleic acid vaccination strategies against infectious diseases

(2015) Małgorzata Anna Marć et al.   Expert Opinion on Drug Delivery

Nucleic acid-sensing TLRs and autoimmunity: novel insights from structural and cell biology

(2015) Karin Pelka et al.   IMMUNOLOGICAL REVIEWS

Potential therapeutic targets in the process of nucleic acid recognition: opportunities and challenges

(2015) Shaoheng He et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Pattern Recognition and Signaling Mechanisms of RIG-I and MDA5

(2014) Stephanie Reikine et al.   Frontiers in Immunology

Cytokine Gene Polymorphisms and Human Autoimmune Disease in the Era of Genome-Wide Association Studies

(2011) Koen Vandenbroeck   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH